Cart
sales@molnova.com
UNC0064-12 hydrochloride (1430089-64-7(free base))
CAS No. ——
UNC0064-12 hydrochloride (1430089-64-7(free base))( —— )
Catalog No. M22768 CAS No. ——
UNC0064-12 hydrochloride is an inhibitor of VEGFR2 extracted from patent WO2013055780A1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 357 | In Stock |
|
| 10MG | 597 | In Stock |
|
| 25MG | 882 | In Stock |
|
| 50MG | 1350 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameUNC0064-12 hydrochloride (1430089-64-7(free base))
-
NoteResearch use only, not for human use.
-
Brief DescriptionUNC0064-12 hydrochloride is an inhibitor of VEGFR2 extracted from patent WO2013055780A1.
-
DescriptionUNC0064-12 hydrochloride is an inhibitor of VEGFR2 extracted from patent WO2013055780A1.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetVEGFR
-
RecptorVEGFR2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight400.91
-
Molecular FormulaC19H25ClN8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.NCCCNc1ccc(Nc2nccc(Nc3cc([nH]n3)C3CC3)n2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. MULTIPLEXED KINASE INHIBITOR BEADS AND USES THEREOF. Patent Application WO/2013/055780 Kind Code: A1
molnova catalog
related products
-
Lenvatinib mesylate
Lenvatinib mesylate (E7080 mesylate), an oral, multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, shows potent antitumor activities.
-
Sinomenine
Sinomenine is a pure alkaloid isolated from the Sinomenium acutum, is utilized in the treatment of rheumatism and arthritis.
-
Veratric acid
Veratric acid plays an important role in producing antibiotics and various dyes.
